Associate Professor at the University of Ferrara, Department of Translational Medicine and for Romagna, Competition Sector: 06/B1 - Internal Medicine, Scientific Disciplinary Sector: MEDS-05/A Internal Medicine. Medical Director under Agreement at the University Hospital of Ferrara.
EDUCATION
Degree in Medicine and Surgery with honours, Specialisation in Endocrinology and Metabolic Diseases with honours, PhD in Medical Physiopathology with honours, Second level Master in Economics and Management of Health Services with top marks.
TEACHING ACTIVITIES
Degree Courses
Medicine and Surgery (Single Cycle Master's Degree, Course Class LM-41)
Dietetics (Three-year Degree Qualifying for the Health Profession of Dietitian, Course Class L/SNT3)
Medical Biotechnology (Three-year Degree, Course Class L-2)
Biotechnology for Translational Medicine (Master's Degree, Course Class LM-9)
Pharmacy (Single Cycle Master's Degree, Course Class LM-13)
Sciences and Techniques of Preventive and Adapted Motor Activity (Master's Degree, Course Class LM-67).
Specialisation Schools
Geriatrics, D.I.68/2015, Internal Medicine, D.I.68/2015, Emergency-Urgency Medicine, D.I.68/2015, Sports and Exercise Medicine, D.I.68/2015, Clinical Pathology and Clinical Biochemistry HEALTHCARE AREA, D.I.716/2016.
MANAGERIAL ACTIVITIES
Director of the School of Specialisation in Geriatrics at the University of Ferrara
Coordinator of the Degree Course in Dietetics (qualifying for the profession of Dietitian) CLASS 3/SNT
Member of the Regional Coordination, Emilia Romagna Region, of the Clinical and Preventive Nutrition Network representing both the University Hospital of Ferrara and the Local Health Unit of Ferrara
Member of the Drug Commission of Area Vasta Emilia Centrale
Member of the Teaching Board PhD in Advanced Therapies and Experimental Pharmacology
Member of the Faculty Council of Medicine, Pharmacy and Prevention.
RESEARCH ACTIVITIES
Research Topics
Her research activity, both pre-clinical and clinical, is focused on Metabolic, Nutritional and Gerontological topics.
Effect of physical activity/inactivity on glucose-lipid metabolism and cross-talk between adipose tissue and muscle.
Clinical intervention areas: subjects with overweight/obesity, with cardiometabolic risk factors. Different intervention models: Bed Rest, physical exercise (Polarised (POL), High Intensity Interval Training (HIIT)).
Diet, nutritional content and cardiometabolic health.
Clinical intervention areas: healthy subjects, with overweight/obesity, with cardiometabolic risk factors, with prediabetes/diabetes. Different models: observational studies and intervention studies (Continuous Energy Restriction (CER), Intermittent Energy Restriction (IER), ketogenic diet, Mediterranean diet, Oral Lipid Load).
Basic research: in vitro study of the metabolic response of adipocytes, human myotubes and HUVEC to saturated and unsaturated lipids.
Management of residual cardiovascular risk and personalised medicine.
Basic research: Modulation of some SNPs on the transcription of genes involved in metabolism, e.g. PPAR-alpha and gamma, induced by saturated/unsaturated fats, lipid-lowering drugs on human monocytes/macrophages.
Relationships between metabolic diseases and neurocognitive decline (PON-1 activity, BDNF).
Clinical intervention areas: subjects with and without neurocognitive function decline. Cardiometabolic health in long-term cancer survivors. Clinical intervention areas: women long-term survivors of breast cancer with or without cardiovascular events.
SARS-CoV-2 related research topics
Tissues as a possible reservoir of SARS-CoV-2 in subjects with current or past infection. Targeting tissue to defeat the epidemic. Clinical intervention areas: risk prevention, development of solutions to counteract and contain the effects of possible future pandemics.
Evaluation of independent clinical-laboratory predictors of clinical outcomes in hospitalised SARS-CoV-2 positive patients. Clinical intervention areas: cross-sectional analysis of COVID-19 patient characteristics to understand and plan their care needs; identifying "the fragile phenotype".
Collaborations
Participation in national and international research groups, including the LIPIGEN Network and the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration.
RESEARCH PROJECTS
She has Scientific Responsibility for International and National Research Projects admitted to funding based on competitive calls that provide for peer review. She carries out research activities funded by public and private entities external to the University of Ferrara.
EDITORIAL ACTIVITIES
Associate Editor: Frontiers in Endocrinology. Member of the Editorial Board: Various international scientific journals.
HEALTHCARE ACTIVITIES
Medical Director under Agreement at the University Hospital Unit of Internal Medicine, University Hospital-University of Ferrara. Responsible for managing and organising the Area for the Study, Diagnosis and Treatment of Metabolic Diseases and Nutrition.
AWARDS AND HONOURS
Elected President of the Board of Directors of the Italian Society for the Study of Atherosclerosis, Tosco-Emilian Section.
EDUCATION
Degree in Medicine and Surgery with honours, Specialisation in Endocrinology and Metabolic Diseases with honours, PhD in Medical Physiopathology with honours, Second level Master in Economics and Management of Health Services with top marks.
TEACHING ACTIVITIES
Degree Courses
Medicine and Surgery (Single Cycle Master's Degree, Course Class LM-41)
Dietetics (Three-year Degree Qualifying for the Health Profession of Dietitian, Course Class L/SNT3)
Medical Biotechnology (Three-year Degree, Course Class L-2)
Biotechnology for Translational Medicine (Master's Degree, Course Class LM-9)
Pharmacy (Single Cycle Master's Degree, Course Class LM-13)
Sciences and Techniques of Preventive and Adapted Motor Activity (Master's Degree, Course Class LM-67).
Specialisation Schools
Geriatrics, D.I.68/2015, Internal Medicine, D.I.68/2015, Emergency-Urgency Medicine, D.I.68/2015, Sports and Exercise Medicine, D.I.68/2015, Clinical Pathology and Clinical Biochemistry HEALTHCARE AREA, D.I.716/2016.
MANAGERIAL ACTIVITIES
Director of the School of Specialisation in Geriatrics at the University of Ferrara
Coordinator of the Degree Course in Dietetics (qualifying for the profession of Dietitian) CLASS 3/SNT
Member of the Regional Coordination, Emilia Romagna Region, of the Clinical and Preventive Nutrition Network representing both the University Hospital of Ferrara and the Local Health Unit of Ferrara
Member of the Drug Commission of Area Vasta Emilia Centrale
Member of the Teaching Board PhD in Advanced Therapies and Experimental Pharmacology
Member of the Faculty Council of Medicine, Pharmacy and Prevention.
RESEARCH ACTIVITIES
Research Topics
Her research activity, both pre-clinical and clinical, is focused on Metabolic, Nutritional and Gerontological topics.
Effect of physical activity/inactivity on glucose-lipid metabolism and cross-talk between adipose tissue and muscle.
Clinical intervention areas: subjects with overweight/obesity, with cardiometabolic risk factors. Different intervention models: Bed Rest, physical exercise (Polarised (POL), High Intensity Interval Training (HIIT)).
Diet, nutritional content and cardiometabolic health.
Clinical intervention areas: healthy subjects, with overweight/obesity, with cardiometabolic risk factors, with prediabetes/diabetes. Different models: observational studies and intervention studies (Continuous Energy Restriction (CER), Intermittent Energy Restriction (IER), ketogenic diet, Mediterranean diet, Oral Lipid Load).
Basic research: in vitro study of the metabolic response of adipocytes, human myotubes and HUVEC to saturated and unsaturated lipids.
Management of residual cardiovascular risk and personalised medicine.
Basic research: Modulation of some SNPs on the transcription of genes involved in metabolism, e.g. PPAR-alpha and gamma, induced by saturated/unsaturated fats, lipid-lowering drugs on human monocytes/macrophages.
Relationships between metabolic diseases and neurocognitive decline (PON-1 activity, BDNF).
Clinical intervention areas: subjects with and without neurocognitive function decline. Cardiometabolic health in long-term cancer survivors. Clinical intervention areas: women long-term survivors of breast cancer with or without cardiovascular events.
SARS-CoV-2 related research topics
Tissues as a possible reservoir of SARS-CoV-2 in subjects with current or past infection. Targeting tissue to defeat the epidemic. Clinical intervention areas: risk prevention, development of solutions to counteract and contain the effects of possible future pandemics.
Evaluation of independent clinical-laboratory predictors of clinical outcomes in hospitalised SARS-CoV-2 positive patients. Clinical intervention areas: cross-sectional analysis of COVID-19 patient characteristics to understand and plan their care needs; identifying "the fragile phenotype".
Collaborations
Participation in national and international research groups, including the LIPIGEN Network and the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration.
RESEARCH PROJECTS
She has Scientific Responsibility for International and National Research Projects admitted to funding based on competitive calls that provide for peer review. She carries out research activities funded by public and private entities external to the University of Ferrara.
EDITORIAL ACTIVITIES
Associate Editor: Frontiers in Endocrinology. Member of the Editorial Board: Various international scientific journals.
HEALTHCARE ACTIVITIES
Medical Director under Agreement at the University Hospital Unit of Internal Medicine, University Hospital-University of Ferrara. Responsible for managing and organising the Area for the Study, Diagnosis and Treatment of Metabolic Diseases and Nutrition.
AWARDS AND HONOURS
Elected President of the Board of Directors of the Italian Society for the Study of Atherosclerosis, Tosco-Emilian Section.
